PTPN13 and neoplasm: After dividing the tumor samples into two groups based on PTPN13 expression (cut-off lower tercile), we observed a non-significant trend towards longer recurrence-free survival in patients with high PTPN13 expression (HR = 1.27; p = 0.33) (Supplementary Figure S4).